Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OneMedNet (ONMD) Shares Outstanding (Weighted Average) (2021 - 2025)

OneMedNet has reported Shares Outstanding (Weighted Average) over the past 5 years, most recently at $14.3 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 0.64% to $14.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.3 million through Dec 2025, down 0.64% year-over-year, with the annual reading at $14.3 million for FY2025, 0.64% down from the prior year.
  • Shares Outstanding (Weighted Average) was $14.3 million for Q4 2025 at OneMedNet, down from $41.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $41.3 million in Q3 2025 and troughed at $2.7 million in Q1 2023.
  • The 5-year median for Shares Outstanding (Weighted Average) is $11.5 million (2022), against an average of $16.0 million.
  • Year-over-year, Shares Outstanding (Weighted Average) tumbled 64.93% in 2023 and then surged 812.4% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $3.3 million in 2021, then rose by 20.58% to $4.0 million in 2022, then skyrocketed by 82.97% to $7.3 million in 2023, then soared by 98.47% to $14.4 million in 2024, then dropped by 0.64% to $14.3 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Shares Outstanding (Weighted Average) are $14.3 million (Q4 2025), $41.3 million (Q3 2025), and $36.8 million (Q2 2025).